Dustin S. Sjuts, President at Revance Therapeutics, Inc. (RVNC), sold 12,178 shares at $5.04 ($62K) on 2024-03-18, disclosed to the SEC on 2024-03-19.
Open-market sale of $62k RVNC by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.31 | 2,967 | $16K | 25.3% |
| 2 | $5.04 | 9,211 | $46K | 74.7% |
| Total | $5.11 avg | 12,178 | $62K | 100% |
| Filing → |
| RVNC | SELL | 2023-03-09 | $1.4M | — | Filing → |